| Old Articles: <Older 4771-4780 Newer> |
|---|
 |
The Motley Fool
April 17, 2008
Brian Lawler |
CVT's Copacetic Cash Management Drugmaker CV Therapeutics signs away a little portion of its royalty stream from a recently approved drug, in order to get a lot back.   |
The Motley Fool
April 17, 2008
Brian Orelli |
Abbott's Not Ailing Abbott produces double-digit growth; investors yawn. |
The Motley Fool
April 17, 2008
Brian Lawler |
The End for (Another) Hepatitis C Drug Candidate ViroPharma stops development of its compound after data showed it may hurt the liver. |
The Motley Fool
April 17, 2008
Brian Orelli |
Headache Over for Pozen and Glaxo? The duo's FDA headache regarding their migraine drug is over, but a new one is about to begin. |
The Motley Fool
April 17, 2008
Brian Orelli |
FDA and Health Insurers Take On Drugmakers The FDA is teaming up with health insurer WellPoint to use the company's vast database of 35 million members' medical records to try find drugs' side effects. |
The Motley Fool
April 17, 2008
Anders Bylund |
Foolish Forecast: Intuitive Surgical Is Worth Every Penny In advance of earnings, let's compare robotic-surgery equipment manufacturer Intuitive Surgical to some of its peers and competitors. |
The Motley Fool
April 16, 2008
Brian Orelli |
Forest Labs' Race Against the Clock Investors don't seem to like Forest Labs' ambitious plans for research and development. |
The Motley Fool
April 16, 2008
Brian Lawler |
Alpharma's Soothing Guidance Alpharma lowers its financial guidance for 2008. Investors, take note. |
The Motley Fool
April 16, 2008
Brian Lawler |
Cephalon Convinces the Continent The pharmaceutical's lead pain drug gets approved for marketing in Europe. |
Chemistry World
April 9, 2008
Richard Van Noorden |
The shortest recipe for Tamiflu US chemists have published the shortest synthesis to date of oseltamivir (Tamiflu), the anti-influenza drug which is also used to treat bird flu. |
| <Older 4771-4780 Newer> Return to current articles. |
